Groupon Q2 Revenue Drops on Health & Beauty Weakness, Guides Below Street
GRPN has more than doubled off its 52-week low of $9.17.
Summary
Groupon's Q2 revenue fell 1% to $124.7M, dragged down by softness in its North American Health, Beauty & Wellness segment. Adjusted EBITDA of $14.8M narrowly beat the $14.6M consensus, but the top-line miss and a 7% drop in unit sales signal ongoing demand challenges. Management guided Q3 revenue to $128M-$130M and full-year 2026 to $513M-$523M, both below Street expectations. This follows a May restructuring that cut 400 jobs and a COO departure, adding to operational uncertainty. The results reinforce concerns about the turnaround's traction, with the stock already trading at a stretched 64x forward earnings.
At the time of this announcement, GRPN was trading at $28.70 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $955.3M. The 52-week trading range was $9.17 to $43.08. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.